Adenosine inhibits lipopolysaccharide-induced cardiac expression of tumor necrosis factor-alpha.

Tumor necrosis factor-alpha (TNF-alpha) is elevated in the failing heart. Very little is known about regulation of TNF-alpha in cardiomyocytes. TNF-alpha expression by macrophages is diminished by adenosine. Therefore, we hypothesized that a similar mechanism might occur in the heart. Neonatal rat myocytes were stimulated with lipopolysaccharide (LPS), and TNF-alpha was measured by ELISA. In the absence of LPS, myocytes did not release TNF-alpha in the medium. After exposure to LPS, TNF-alpha increased to 70.1+/-3.5 pg/mL at 6 hours. Immunofluorescent staining confirmed that TNF-alpha was expressed in myocytes. Adenosine decreased TNF-alpha in a dose-dependent manner (1 to 100 micromol/L, 37% to 65% decrease, P<.01). Adenosine also decreased TNF-alpha in cell homogenates by 78% (P<.0001). The effect of adenosine could be replicated by the A2 agonist PD-125944 (DPMA), by cAMP agonists 8-bromo-cAMP, forskolin, and Ro 20-1724, but not by A1 and A3 agonists. Conversely, the effect of adenosine could be suppressed by the adenylate cyclase inhibitor MDL-12,330. Adenosine also inhibited TNF-alpha in adult rat ventricular myocytes (-60%, P<.005) and rat papillary muscles (-55%, P<.05). In neonatal myocytes, adenosine normalized LPS-induced calcium changes and improved LPS-induced negative inotropic (P<.01) and negative lusitropic (P<.01) effects. Our results demonstrate that adenosine can significantly diminish TNF-alpha levels in the heart. The effect appears to be mediated by the A2 receptor and transduced through a G protein-adenylyl cyclase pathway. These results may explain some cardioprotective effects of adenosine and provide a novel pharmacological intervention in congestive heart failure.

[1]  A. Feldman,et al.  Interleukin-1 beta inhibits phospholamban gene expression in cultured cardiomyocytes. , 1997, Circulation research.

[2]  A. Koretsky,et al.  Dilated Cardiomyopathy in Transgenic Mice With Cardiac-Specific Overexpression of Tumor Necrosis Factor-α , 1997 .

[3]  A. Demetris,et al.  Cardiac-specific overexpression of tumor necrosis factor-alpha causes lethal myocarditis in transgenic mice. , 1997, Journal of cardiac failure.

[4]  J. Dobson,et al.  Adenosine A2 receptor function in rat ventricular myocytes. , 1997, Cardiovascular research.

[5]  J. Morley,et al.  A New Cyclic AMP-independent, Gs-mediated Stimulatory Mechanism via the Adenosine A2a Receptor in the Intact Cardiac Cell* , 1996, The Journal of Biological Chemistry.

[6]  W. Schmitz,et al.  Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase. , 1996, Journal of molecular and cellular cardiology.

[7]  G. Firestein,et al.  Inhibition of TNF-alpha expression by adenosine: role of A3 adenosine receptors. , 1996, Journal of immunology.

[8]  H. Oral,et al.  Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). , 1996, Journal of the American College of Cardiology.

[9]  L. Belardinelli,et al.  Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology , 2012, Springer US.

[10]  A. Dubin,et al.  TNFα receptor expression in rat cardiac myocytes: TNFα inhibition of L‐type Ca2+ current and Ca2+ transients , 1995 .

[11]  D. Mann,et al.  Expression and functional significance of tumor necrosis factor receptors in human myocardium. , 1995, Circulation.

[12]  D. Mann,et al.  Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration. , 1995, The Journal of clinical investigation.

[13]  C. Long,et al.  Interleukin-1 beta induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture. , 1995, The Journal of clinical investigation.

[14]  R. Robinson,et al.  β2-Adrenergic Receptor Actions in Neonatal and Adult Rat Ventricular Myocytes , 1995 .

[15]  J. Shryock,et al.  Myocardial Adenosine Receptors , 1995 .

[16]  W. Buurman,et al.  Differential regulatory effects of adenosine on cytokine release by activated human monocytes. , 1994, Journal of immunology.

[17]  D. Heinrich,et al.  Influence of polyclonal immunoglobulins on the polymorphonuclear leukocyte response to lipopolysaccharide of Salmonella enteritidis as measured with luminol-enhanced chemiluminescence , 1994, Infection and immunity.

[18]  D. Wagner,et al.  Existence and Role of Substrate Cycling Between AMP and Adenosine in Isolated Rabbit Cardiomyocytes Under Control Conditions and in ATP Depletion , 1994, Circulation.

[19]  A. Deisseroth,et al.  Interaction of nuclear proteins with an AP‐1/CRE‐like promoter sequence in the human TNF‐α gene , 1994 .

[20]  J. Lemasters,et al.  Suppression of lipopolysaccharide‐stimulated release of tumor necrosis factor by adenosine: Evidence for A2 receptors on rat kupffer cells , 1994, Hepatology.

[21]  W. Schmitz,et al.  Pharmacological characterization of A2-adenosine receptors in guinea-pig ventricular cardiomyocytes. , 1994, Journal of molecular and cellular cardiology.

[22]  L. Vaca,et al.  Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. , 1993, The Journal of clinical investigation.

[23]  J. A. Robinson,et al.  INDUCTION OF TNFα AND TNFβ GENE EXPRESSION IN RAT CARDIAC TRANSPLANTS DURING ALLOGRAFT REJECTION , 1993 .

[24]  W. Tourtellotte,et al.  On classification of post-mortem multiple sclerosis plaques for neuroscientists , 1993, Journal of Neuroimmunology.

[25]  D. Morrison,et al.  Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge. , 1993, Journal of immunology.

[26]  J. Pearson,et al.  Effect of 5'-deoxy-5'-isobutylthioadenosine on formation and release of adenosine from neonatal and adult rat ventricular myocytes. , 1993, The Biochemical journal.

[27]  C. Velasco,et al.  Adenosine attenuates reperfusion injury following regional myocardial ischaemia. , 1993, Cardiovascular research.

[28]  A. Tucker,et al.  Cloned receptors and cardiovascular responses to adenosine. , 1993, Cardiovascular research.

[29]  J. H. Johnson,et al.  The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. , 1992, The Journal of clinical investigation.

[30]  S. Abramson,et al.  Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. , 1992, Journal of immunology.

[31]  R. Berne,et al.  Protective Effects of Adenosine In Myocardial Ischemia , 1992, Circulation.

[32]  J. Vilček,et al.  Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. , 1991, The Journal of biological chemistry.

[33]  J. Cai,et al.  Lymphocyte adhesion to cultured Peyer's patch high endothelial venule cells is mediated by organ-specific homing receptors and can be regulated by cytokines. , 1990, Journal of immunology.

[34]  H. Fillit,et al.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.

[35]  R. Biagini,et al.  Comparative toxicity of allylamine and acrolein in cultured myocytes and fibroblasts from neonatal rat heart. , 1989, Toxicology.

[36]  C. Tannenbaum,et al.  Lipopolysaccharide-induced gene expression in murine peritoneal macrophages is selectively suppressed by agents that elevate intracellular cAMP. , 1989, Journal of immunology.

[37]  S. B. Kramer,et al.  Adenosine: a physiological modulator of superoxide anion generation by human neutrophils , 1983, The Journal of experimental medicine.

[38]  F. Hanley,et al.  Direct measurement of left ventricular interstitial adenosine. , 1983, The American journal of physiology.

[39]  H. Samuels,et al.  Depletion of L-3,5,3'-triiodothyronine and L-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone. , 1979, Endocrinology.